Radium-223 Dichloride Long-term Follow-up Program
Phase 3
Completed
- Conditions
- eoplasm Metastasis / Bone and Bones
- Registration Number
- JPRN-jRCT2080224668
- Lead Sponsor
- Bayer Yakuhin, Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- Male
- Target Recruitment
- 0
Inclusion Criteria
Subject was previously enrolled in a selected company sponsored feeder trial, and has received at least 1 dose of radium 223 dichloride or placebo in the feeder trial
Exclusion Criteria
Not applicable to this follow up study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method